re: some info on gtg/patent insurance i understand that applera's patent breaching sales are approx USD2bio approx 5 to 6 times genzyme's sales that are affected by gtg's patents. now genzyme settled before the markman hearing,so now applera's
licence fee will be much higher because they have played hard ball,applera is going to have to pay up big time, hopefully in the many tens of mio USD.
- Forums
- ASX - By Stock
- some info on gtg
GTG
genetic technologies limited
Add to My Watchlist
0.00%
!
3.9¢

re: some info on gtg/patent insurance i understand that...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
3.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $52.08M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
GTG (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online